To help expand the Life Science business in China, the Intellectual Property & Science China team delivered its first PharmaVision event on April 14^th, 2012.

08 May 2012Thomson Reuters

The theme was “Intelligent Information Accelerates Drug Research and Development” and explored the important role of intelligent information in the Life Sciences research and development process. More than 130 life sciences professionals, including many chief executive officers, attended the event where Life Sciences was able to showcase how its products and services can accelerate pharmaceutical innovation in China.

“This conference gives us an opportunity to communicate with influential life sciences thought leaders in China. PharmaVision 2012 – China is a milestone that will help our customers improve research and development efficiency and strengthen business competiveness by intelligence information and professional services”

-David Liu, Managing Director, China, IP & Science

“This event was thought-provoking and the information shared in the event is really helpful to our work in research and development procedure,”

-Qingsong Wang, head of the Cooperative Research Department of Simcere Pharmaceutical Company.

Among the participants were key opinion leaders, such as:

• Hualiang Jiang, Deputy Director, Shanghai Institute of Materia Medica of Chinese Academy of Sciences (CAS)
• Jingkang Shen, Professor of Shanghai Institute of Materia Medica of CAS and President of Central Research Institute, Shanghai Pharmaceuticals Holding Co., Ltd.
• Hongkang Mei, Associate Director of Bioinformatics, GSK China

The event also acted as an opportunity for our Life Sciences professionals to learn more about hot topics in the industry. Sessions included: Revival of Drugs, Opportunities and Challenges for Chinese Innovative Drugs, Opportunities in Systems Biology to Discover Mechanisms and Repurpose Drugs for CNS Diseases, etc. Some attendees even used Thomson Reuters data as part of their presentations and discussions.